Precision Medicine

New GLP-1 Drugs Target Brain Reward Centers to Curb Cravings
Tech & Innovation New GLP-1 Drugs Target Brain Reward Centers to Curb Cravings

The persistent urge to consume calorie-dense foods often has little to do with actual nutritional deficits and everything to do with how our internal circuitry processes pleasure. While the first generation of weight-loss medications focused primarily on the stomach and metabolic signals, a

How Can Better Infrastructure Save Precision Medicine?
Research & Development How Can Better Infrastructure Save Precision Medicine?

The biological revolution of the current decade has granted scientists the unprecedented ability to map the smallest genetic variations that drive complex diseases, yet the physical and digital pipelines connecting these discoveries to real patients remain dangerously frayed. While laboratories

Can AI Muscle Analysis Predict Cardiometabolic Risk?
Tech & Innovation Can AI Muscle Analysis Predict Cardiometabolic Risk?

The traditional reliance on Body Mass Index as a primary indicator of metabolic health is rapidly being eclipsed by advanced diagnostic tools capable of peering into the microscopic composition of human tissue. While weight and height provide a rough estimate of physical status, they fail to

Can GLP-1 Weight Loss Drugs Replace Physical Activity?
Research & Development Can GLP-1 Weight Loss Drugs Replace Physical Activity?

Achieving a profound metabolic transformation through a weekly injection might seem like a modern medical miracle, but the biological reality of weight loss suggests that needles alone cannot build a resilient body. The rise of GLP-1 receptor agonists like semaglutide and liraglutide has undeniably

Can Myqorzo Solve the Challenges of Non-Obstructive HCM?
Research & Development Can Myqorzo Solve the Challenges of Non-Obstructive HCM?

The landscape of cardiovascular medicine is witnessing a transformative shift with the emergence of Myqorzo, a targeted therapy designed by Cytokinetics to tackle one of the most stubborn challenges in cardiology: non-obstructive hypertrophic cardiomyopathy (HCM). For years, patients suffering from

New Study Identifies Distinct Subgroups of Parkinson’s
Tech & Innovation New Study Identifies Distinct Subgroups of Parkinson’s

The long-held medical consensus that Parkinson’s disease represents a single path of neurological decay is crumbling under the weight of new evidence showing that patients are actually suffering from entirely different biological failures. For decades, the medical community categorized this

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later